<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Acne Vulgaris: Establishing Effectiveness of Drugs Intended for Treatment; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Acne Vulgaris: Establishing Effectiveness of Drugs Intended for Treatment; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2018-05-22 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry entitled "Acne Vulgaris: Establishing Effectiveness of Drugs Intended for Treatment." This guidance provides recommendations to industry for establishing the clinical effectiveness of drugs for the treatment of acne vulgaris (acne). This guidance finalizes the draft guidance for industry entitled "Acne Vulgaris: Developing Drugs for Treatment," issued September 19, 2005.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2018-10928</p>
    <p><strong>Publication Date:</strong> 2018-05-22</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2018/05/22/2018-10928/acne-vulgaris-establishing-effectiveness-of-drugs-intended-for-treatment-guidance-for-industry">https://www.federalregister.gov/documents/2018/05/22/2018-10928/acne-vulgaris-establishing-effectiveness-of-drugs-intended-for-treatment-guidance-for-industry</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2018-10928</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
